{"database": "lobbying", "table": "lobbying_activities", "rows": [[2824527, "388f4952-ec6e-4fc1-be5d-fd3da4fe9d44", "Q2", "RICCHETTI INCORPORATED", 62778, "IPSEN BIOPHARMACEUTICALS, INC.", 2022, "second_quarter", "PHA", "Issues related to pharmaceutical industry, generally Issues related to development of products to treat limb spasticity and fibrodysplasia ossificans progressiva (FOP)", "HOUSE OF REPRESENTATIVES", 20000, null, 0, 0, "2022-07-18T14:09:37-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2824527"], "units": {}, "query_ms": 82.93130714446306, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}